Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stamatis

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
British Journal of Cancer|December 10, 1999
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trialW Eberhardt, G Stamatis, M Stuschke, et al.
British Journal of Cancer|July 28, 2012
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerD C Christoph, S Kasper, T C Gauler, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2012
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT studyM Kreuter, J Vansteenkiste, J R Fischer, et al.
Pneumologie (Stuttgart, Germany)|March 11, 2010
[Prevention, diagnosis, therapy, and follow-up of lung cancer]G Goeckenjan, H Sitter, M Thomas, et al.
Pneumologie (Stuttgart, Germany)|December 16, 2010
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer SocietyG Goeckenjan, H Sitter, M Thomas, et al.
Pneumologie (Stuttgart, Germany)|August 11, 2011
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]G Goeckenjan, H Sitter, M Thomas, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
British Journal of Cancer|December 10, 1999
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trialW Eberhardt, G Stamatis, M Stuschke, et al.
British Journal of Cancer|July 28, 2012
βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancerD C Christoph, S Kasper, T C Gauler, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2012
Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT studyM Kreuter, J Vansteenkiste, J R Fischer, et al.
Pneumologie (Stuttgart, Germany)|March 11, 2010
[Prevention, diagnosis, therapy, and follow-up of lung cancer]G Goeckenjan, H Sitter, M Thomas, et al.
Pneumologie (Stuttgart, Germany)|December 16, 2010
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer SocietyG Goeckenjan, H Sitter, M Thomas, et al.
Pneumologie (Stuttgart, Germany)|August 11, 2011
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]G Goeckenjan, H Sitter, M Thomas, et al.
Pageof 8